“Which carries more risk: participation or avoidance?” – the big question many in the corporate world face when it comes to social media.
For a highly regulated industry like #pharma, avoidance is often the easier, safer choice – but is it the most effective? Not necessarily, as convincingly articulated by Roger Christie, keynote speaker of the MedNews Aust/NZ event, “Pharma reputation: Building trust in the digital age”.
Great insights and discussions were shared on this and other themes surrounding reputation within the pharma industry, with one thought resonating with everyone in the room: in order to be trusted, you have to be liked; in order to be liked, you have to be known.
As panellist John Morton argued, it all comes down to "what’s your story, who are you trying to communicate with and for what purpose?" These are very useful parameters for the pharma industry to take stock of and drive more proactive communication on how it contributes to health, wellbeing and productivity within our societies today.
Looking good Luke S.